Monovalent XBB.1.5 COVID|19 vaccine effectiveness against ...

(PDF) Monovalent XBB.1.5 COVID-19 vaccine effectiveness against ...

VE against COVID19-related-death was 58% (95%CI: 42 to 69) and 48% (95%CI: 38 to 57), respectively, in both age groups. VE estimates against ...

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against ...

Abstract BackgroundMonovalent XBB.1.5 vaccine was administered among those aged ≥65 years in EU/EEA countries in autumn 2023; soon after SARS-Cov-2 ...

Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a ...

... XBB.1.5 monovalent vaccine effectiveness (VE) against COVID-19 hospitalisation and death in b...

Estimates of vaccine effectiveness of the updated monovalent XBB ...

Conclusion: The short-term effectiveness of the XBB.1.5 vaccine against symptomatic COVID-19 infection, hospitalization, and receipt of oxygen therapy in ...

COVID-19 vaccines: Canadian Immunization Guide - Canada.ca

Based on early study results, the short-term relative vaccine effectiveness of XBB.1.5 mRNA COVID-19 vaccines in adults has been estimated to be ...

COVID-19 Variant Update - IDSA

1.5 variant, which is the current target of monovalent COVID-19 vaccines. ... 1.5 vaccine effectiveness against JN.1 were similar to preliminary ...

discover.HSLS - "COVID-19"

Background There is limited data on the effectiveness of the SARS-CoV-2 monovalent XBB.1.5 variant vaccine against COVID-19 mortality ...

Spikevax (previously COVID-19 Vaccine Moderna)

Spikevax XBB.1.5 contains andusomeran, an mRNA molecule with instructions for producing a protein from the Omicron XBB.1.5 subvariant of SARS-CoV-2;; Spikevax ...

Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in ...

To increase efficacy against the predominant strains as of the second half of 2023, the updated vaccine formulation contained only the mRNA of ...

Comparative effectiveness of the monovalent XBB.1.5-containing ...

Abstract. Objective To estimate the effectiveness of vaccination with a monovalent XBB.1.5-containing covid-19 mRNA vaccine against severe covid ...

Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted ...

Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December ...

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a ...

... XBB.1.5 monovalent vaccine effectiveness (VE) against COVID-19 hospitalisation and death in booster-eligible ≥ 65-year-olds, during October ...

Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs ...

Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection ...

Comparative effectiveness of the monovalent XBB.1.5-containing ...

ABSTRACT ObjectiveTo estimate the effectiveness of vaccination with a monovalent XBB.1.5-containing covid-19 mRNA vaccine against severe covid-19 across ...

Do bivalent boosters work against XBB.1.5? Vaccine questions ...

... on coronavirus vaccine effectiveness. Story continues below advertisement. She added that the latest study did not take into account previous ...

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 ...

... against multiple Omicron XBB-related sublineages, including XBB.1.5, XBB ... 1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) has ...

19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA

... XBB.1.5 monovalent vaccine effectiveness (VE) against COVID- 19 hospitalisation and death in booster- eligible ≥ 65- year- olds, during. October–November ...

Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID ...

Effectiveness of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccination against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineage hospitalization.

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against ...

Journal: Expert Review of Vaccines. DOI: 10.1080/14760584.2024.2428800. Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths.

Monitoring reports of the effectiveness of COVID-19 vaccination

... on which vaccine individuals were last eligible to receive. This includes the effectiveness of the latest booster programme; XBB.1.5 monovalent boosters ...